Karnataka: Batch of popular beer brand recalled citing health concerns
BENGALURU : After finding sediments in a popular brand of beer, the excise department has recalled the bottles supplied to depots and retail stores, citing health concerns. An order to recall the…
Drug overpricing: Govt plans amnesty scheme to recover dues from pharma companies
In a bid to tackle overpricing in the pharmaceutical sector, the government is planning an amnesty scheme to recover dues from pharmaceutical companies, CNBC Aawaz reported. The National Pharmaceutical Pricing Authority (NPPA), responsible for…
WS DETAILS NCB Seizes 2,724 Kg Of Tablets For Medicinal Use Between 2020 To 2022
New Delhi : The Narcotic Control Bureau (NCB) has seized a total of 2,724 kilogram of tablets having medicinal use in the three years from 2020 to 2022 under the…
E-pharmacy platforms should strictly adhere to draft rules: MoS SP Baghel
The Union Minister of State for Health and Family Welfare Prof. SP Baghel said on Tuesday that Central Drugs Standard Control Organization (CDSCO) has issued showcause notices to various firms engaged in online sale…
Show-cause notices issued to 143 pharma firms after inspections
New Delhi: The Central Drugs Standard Control Organisation along with state licensing authorities has conducted risk-based inspections of 162 pharmaceutical firms and issued show-cause notices in 143 cases, Union Health…

Diabetic drug metformin found to act on brain
Hetero debuts semaglutide generic in emerging markets
LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial
Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority
Stem cell therapy for autism illegal: NMC advisory
India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework
Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic
NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise
Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha
Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS